Objective: Our major hypothesis is that cyclic adenosine-39,59-monophosphate (cAMP)-mediated modulation of neurotransmitter release plays different roles at low and high activity of the sympathetic nervous system. We further hypothesize that cAMP-mediated neuromodulation might underlie disparate neurovascular control in mesenteric arteries and veins. Methods: Electrical field stimulation (EFS)-evoked overflow of noradrenaline (NA) was evaluated in the absence or presence of activators and inhibitors of cAMP-dependent pathway at low (4 Hz) and high (16 Hz) frequencies of stimulation of endothelium-denuded secondary and tertiary branches of the canine isolated inferior mesenteric arteries and veins. The content of NA in samples of the superfusates collected before and during nerve stimulation was assayed by high-performance liquid chromatography (HPLC) technique in conjunction with electrochemical detection. Student's t-test and ANOVA analyses were applied for statistical analysis. Results: Activation of cAMP-dependent pathway with either isoproterenol (ISO, 10 mM), forskolin (1 mM), dibutyryl cAMP (100 mM) or combined site-specific activators of cAMP-dependent 6 protein kinase (PKA) [i.e. N -phenyl-adenosine-39,59-cyclic monophosphate, 8-(6-aminohexyl) aminoadenosine-39,59-cyclic monophosphate, and the Sp-isomer of 5,6-dichloro-1-D-ribofuranosylbenzimidazole-39,59-cyclic monophosphorothioate, each 100 mM] caused an enhancement of the EFS-evoked overflow of endogenous NA at 16 Hz of stimulation but was without an effect at 4 Hz of stimulation both in artery and vein. The EFS (16 Hz)-evoked overflow of NA in vein was also increased in the presence of inhibitors of phosphodiesterase (PDE) III and PDE IV (i.e. milrinone, 0.4 mM, and roilpram, 30 mM), whereas these inhibitors did not affect the overflow of NA in the artery. The facilitating effect of activators of cAMP-dependent pathway on the EFS-evoked release of NA at 16 Hz appears to be more pronounced in the vein than in artery. The increasing effect of ISO (10 mM) was inhibited with either propranolol (1 mM) or the adenylyl cyclase (AC) inhibitor [9-(tetrahydro-29-furyl)adenine] (SQ 22,536, 100 mM) in both blood vessels. The ISO effect was inhibited by the PKA inhibitor 14-22 amide (PKI ), 1 mM, in the artery but not in vein. The enhancing effect of FSK was 14 -22 inhibited by pretreatment of the tissue with SQ 22,536, 100 mM, or the PKA inhibitors PKI , 1 mM, and 4-cyano-3- 14 -22 methylisoquinoline, 50 nM. However, the inhibitors alone did not significantly change the EFS-evoked overflow of NA in both blood vessels. Conclusions: Activation of AC-cAMP-PKA pathway appears to play a role in modulating NA release at higher stimulation frequencies as might be expected during stress, strenuous exercise, or hemorrhage. The AC-cAMP pathway plays a more pronounced role in the autonomic neural control of mesenteric veins than of the corresponding arteries, whereas the PKA contribution is more distinct in the arteries.
likely that the two vascular networks demonstrate distinct 2 . Methods activities of signal transduction pathways that mediate neurotransmitter release. There is evidence that raised 2 .1. Tissue preparation intracellular levels of cyclic adenosine-39,59-monophosphate (cAMP) can increase noradrenaline (NA) release Sixty-one mongrel dogs of either sex (averaging 15 kg) from both central and peripheral neurons suggesting a role were obtained from vendors licensed by the United States for this nucleotide in the regulation of sympathetic neuroDepartment of Agriculture. The use of dogs for these transmission [6] . The formation of cAMP from adenosineexperiments was approved by the University of Nevada's 59-triphosphate (ATP) is caused by virtue of activating of a Animal Care and Use Committee. The animals were family of adenylyl cyclases (AC) [7] . The major target sacrificed with an overdose of pentobarbitone sodium (100 molecule of cAMP is cAMP-dependent protein kinase mg / kg intraperitoneally) which is consistent with the (PKA) that mediates its effects through phosphorylation of recommendations of the Panel on Euthanasia of the specific substrates including components of neurotransAmerican Veterinary Medical Association. The investigamitter release machinery [7] [8] [9] . Thus, differential activity tion conforms with the Guide for the Care and Use of of cAMP-mediated mechanisms might underlie differential Laboratory Animals published by the US National Instineurovascular control in arteries and veins.
tutes of Health (NIH publication no. 85-23, revised 1996). Prejunctional a -adrenoceptors that are preferentially
The abdomen was opened and segments of second and 2 coupled with G -group G-proteins and downregulate AC third order branches of the inferior mesenteric artery (0.7-i [10] appear to more prominently modulate neurotrans-1 mm in diameter) and vein (0.9-1.2 mm in diameter) mitter release in the mesenteric veins than in the correwere dissected out and bathed in regular Krebs solution of sponding arteries [5] indirectly suggesting that distinct the following composition: 150 mM NaCl, 4.6 mM KCl, AC-associated mechanisms of neurotransmitter release 1.2 mM MgCl , 2.5 mM CaCl , 24.8 mM NaHCO , AC [11] . The general validity of this assumption has been veins (46.8861.24 mg wet weight, n574) were placed in questioned however, by findings which imply that cAMP 200-ml BRANDEL superfusion chambers as previously is not always involved in the a -adrenoceptor modulation described [4, 5, 15, 16] . After 45 min equilibration, the 2 of NA release [12, 13] . Therefore, controversy still remains tissues were subjected to a 30-s 'conditioning' stimulation regarding the contribution of this pathway to the function with a train of square wave pulses of 0.3 ms duration and a of the prejunctional a -adrenoceptors. Consequently, both frequency of 4 Hz. Thirty minutes later the blood vessels 2 cAMP-and prejunctional a -adrenoceptor-mediated moduwere subjected to EFS for 2 min with a train of supra-2 lation of neurotransmitter release might have different threshold pulses of 0.3 ms duration at 4 Hz followed by patterns and / or frequency dependence in various systems.
EFS at 16 Hz 30 min later. Samples of the superfusion The role of cAMP-mediated mechanisms in neurotranssolution were collected before the electrical stimulation mitter release in arteries and veins from the same vascular (resting overflow) and during the electrical stimulation bed has not been previously addressed.
(electrically-evoked overflow) in ice-cold test tubes. SamThe present study was carried out therefore, to examine ples were analyzed for NA content by high-performance and compare the effects of activators and inhibitors of liquid chromatography (HPLC) technique in conjunction AC-cAMP-PKA pathway on NA release in response to with electrochemical detection. In some experiments, EFS of postganglionic nerve terminals in canine mesentissues were superfused with either activators [i.e. isoteric arteries and the corresponding veins at low and high proterenol, ISO, 10 mM; forskolin, FSK, 1 mM; 1,9-frequency of stimulation. These experiments provide a dideoxy-FSK, 1 mM; dibutyryl cAMP, 100 mM; milrinone, basis for understanding how cyclic nucleotide systems 0. (3.0), LiCl (10.0), and methanol 3% v / v in deionized There were no detectable amounts of NA in samples water. The pH was adjusted to 2.6 with o-phosphoric acid.
collected for 2 min before stimulation of endothelium-free The electrochemical detector was equipped with a glassy canine mesenteric arteries or veins suggesting that spontacarbon electrode and NA was detected using amperometry neous efflux of NA does not occur under our experimental mode at a potential of 0.5 V. The HPLC system was conditions. EFS of both the canine mesenteric artery and controlled by and data collected by a HP Kayak XA vein evokes overflow of NA at 4 Hz and 16 Hz of computer equipped with HP ChemStation (A.06.03) softstimulation. The EFS-evoked NA overflow at 4 Hz was ware from Hewlett Packard (Agilent Technologies).
0.004560.0008 pmol / mg tissue (n512) in the artery and The amounts of NA in each sample were calculated 0.01260.002 pmol / mg tissue (n513) in vein, whereas at from calibration curves of NA standards run simultaneous-16 Hz of stimulation the overflow of NA was ly with every set of unknown samples. Results were 0.03260.0026 (n514) and 0.11160.022 (n512) in the normalized for sample volume and tissue weight and the artery and vein, respectively. Thus, the overflow of NA in overflow of NA was expressed in pmol / mg tissue.
vein exceeded the EFS-evoked overflow of NA in artery both at 4 and 16 Hz of stimulation (Fig. 1, controls) .
.4. Drugs
Previous study in our laboratory [5], using procedures and EFS parameters virtually identical to those employed in the Forskolin, isoproterenol, propranolol, [9-(tetrahydro-29-present study, indicates that pretreatment of the tissue with furyl)adenine] (SQ 22,536), 1,9-dideoxyforskolin, ethyleither tetrodotoxin (1 mM) or guanethidine (10 mM) ene-diamine tetraethylacetic acid (EDTA), 1-heptanesulinhibits the EFS (4 and 16 Hz)-evoked NA overflow in fonic acid and lithium chloride were from Sigma (St.
both blood vessels suggesting that NA originates exclu- 6 Louis, MO). N -Phenyl-adenosine-39,59-cyclic monophossively from the postganglionic sympathetic nerve terminals phate (6-Phe-cAMP), 8-(6-aminohexyl) aminoadenosineunder these experimental conditions. 39,59-cyclic monophosphate (8-AHA-cAMP), and the Spisomer of 5,6-dichloro-1-D-ribofuranosylbenzimidazole-3 .2. Raising cAMP levels facilitates the EFS-evoked NA 39,59-cyclic monophosphorothioate (Sp-5, 6-DCl-cBIMPS) release were from BioLog (La Jolla, CA). Dibutyryl cyclic AMP, milrinone, rolipram, myristoylated PKA inhibitor [14] [15] [16] [17] [18] [19] [20] [21] [22] Fig . 1 shows the results of numerous maneuvers for amide (PKI ), 4-cyano-3-methylisoquinoline (CMI) stimulating AC-cAMP-PKA pathway. Original traces of 14 -22 were from Calbiochem (La Jolla, CA). FSK, 1,9-dideoxychromatograms obtained by assaying the superfusate sam-FSK, milrinone, rolipram, and CMI were dissolved in 50% ples collected during EFS at 16 Hz of artery (Fig. 1C ) and dimethylsulfoxide (DMSO) and further diluted in double vein (Fig. 1D) are shown, as well. Isoproterenol (ISO, 10 mM), an agent that is known to activate AC via activation of G -protein coupled b-adrenos ceptors [11] , had no effect on the EFS-evoked overflow of NA at 4 Hz of stimulation in both blood vessels (Fig. 1A) . At 16 Hz however, the NA overflow was enhanced to 0.06560.005 pmol / mg tissue (n54) in the artery, and to 0.20660.026 pmol / mg tissue (n54) in the vein (P,0.05 as compared to controls) (Fig. 1B-D) . The results with ISO suggest that stimulation of AC and production of cAMP might lead to facilitation of the EFS-evoked NA release at high frequency of stimulation but not at low frequency of stimulation. Other maneuvers that also in- (Fig. 1B-D) . Likewise, combined milrinone PKI abolished the enhancing effect of ISO only in 14 -22 and rolipram increased the NA overflow at 16 Hz to arteries, whereas in the veins this effect of ISO remained 0.17460.017 pmol / mg tissue (n56) in the vein (Fig. 1B intact (Fig. 3) suggesting that PKA is more involved in and D) although it did not affect significantly the EFSmediating the effects of b-adrenoceptor activation in the evoked overflow of NE in the artery (Fig. 1B and C (Fig. 4) suggesting that inhibition 1B). However, none of these interventions significantly of the resting activity of either AC or PKA might not be affected the NA overflow at 4 Hz in both blood vessels sufficient to modulate neurotransmitter release. (Fig. 1A) . 1,9-Dideoxy-FSK, a structural analog of FSK that lacks AC stimulating activity [17] was without an effect in both blood vessels (Fig. 1A and B) .
4 . Discussion The EFS-evoked overflow of NA at 16 Hz can also be facilitated by direct activation of PKA. Combined adminisThe arteries and veins from the splanchnic circulation tration of the site-selective PKA activators 6-Phe-cAMP, are densely innervated [3, 22, 23] and the two vascular 8-AHA-cAMP, and Sp-5,6-DCl-cBIMPS (each at 100 mM) enhanced the EFS (16 Hz)-evoked overflow of NA to 0.09760.01 pmol / mg tissue (n53) and to 0.14060.013 pmol / mg tissue (n53) in the artery and vein, respectively (Fig. 1B-D) .
.3. Inhibitors of AC /PKA do not affect EFS-evoked release of NA
Both SQ 22,536, an inhibitor of AC [18, 19] , and PKI amide, a membrane permeant (myristoylated) 14 -22 protein kinase A inhibitor [20] , significantly reduced the (Fig. 2) [6, 29] although a direct correlation between cAMP-mediated pathways and release of neurotransmitters is sometimes difficult to identify [13, 30] . The role of cAMPmediated mechanisms in neurotransmitter release in arteries and veins from the same circulatory bed has not been previously addressed.
In the present study we have directly measured the EFS-evoked overflow of endogenous NA upon activation or inhibition of the AC-cAMP-PKA pathway in isolated strips of the canine inferior mesenteric artery and vein. Several lines of evidence suggest that cAMP may be an important intracellular messenger in regulating neurotransmitter release in the mesenteric vasculature primarily at high frequency of stimulation. For example, activation of AC elicited with b-adrenoceptor stimulation and consequent activation of the guanine nucleotide-binding protein G with ISO led to a facilitated overflow of NA at 16 s Hz but not at 4 Hz of nerve stimulation. The enhancing effect of ISO was reduced by the AC inhibitor SQ 22,536. Further, direct activation of AC with FSK enhanced the NA overflow at 16 Hz but not at 4 Hz of stimulation both in artery and vein. The effect of FSK was reduced by the AC inhibitor SQ 22,536. This observation together with the finding that the inactive analog of FSK, 1,9-dideoxy-FSK, had no effect on neurotransmitter release, provide functional evidence that the FSK-induced enhancement of EFS-evoked overflow of NA is due primarily to increased AC activity. Similar effects of FSK and ISO have previ- been shown to cause coordinated up-regulation of gene expression and enzyme activities of three catecholaminesynthesizing enzymes (tyrosin hydroxylase, dopamine beta-hydroxylase, and phenyethanolamine N-methyltrannetworks differ significantly in the mechanisms of neurosferase) resulting in a large increase in NA content and vascular control [1-5,24] which might contribute to servdramatic release in primary cultured bovine adrenoing distinct functions (i.e. resistance vs. capacitance) in the medullary chromaffin cells [33] . This large enhancement peripheral circulation. Besides, distinct mechanisms of of catecholamine release implicates an important physioneurovascular control might be involved at low and high logical role for cAMP in the regulation of in vivo activities of the autonomic nervous system. For example, sympathetic activities. Exogenous application of cAMP the prejunctional a -adrenoceptor mediated modulation of (i.e. membrane permeant dibutyryl cAMP) in the present 2 neurotransmitter release generally appears to be an imstudy caused a similar enhancement of the EFS-evoked portant feedback mechanism at lower frequencies of NA overflow at 16 Hz of stimulation both in artery and stimulation [5, [25] [26] [27] . Likewise, the role of N-type voltvein, whereas at 4 Hz of stimulation dibutyryl cAMP 21 age-operated Ca channels appears to be more prominent produced no effect. at lower frequencies of nerve stimulation. On the other
The levels of cAMP in the tissue are modulated by the 21 hand, the role of P/ Q-type neuronal Ca channels inactivity of various PDEs. Of particular significance for creases with stimulation frequency [28] . Therefore, the role cAMP are PDE III and PDE IV [34] . Blockade of the PDE of intracellular signal transduction pathways in neuro-III and PDE IV activity in the mesenteric vein also led to transmitter release might also vary at low and high levels an increase of the EFS-evoked overflow of NA at 16 Hz of autonomic nervous system activity.
but not at 4 Hz of stimulation. This observation is A large number of hormones, neurotransmitters and particularly intriguing since it suggests that the basal other signal substances utilize cAMP as an intracellular production of cAMP in vein, unaltered by metabolism, is second messenger. Cyclic AMP has generally been implisufficient to lead to activation of neurotransmitter release cated as an important mediator of neuroeffector transmisat high frequency of nerve stimulation. This result also sion in both the central and peripheral nervous systems raises the interesting possibility that an additional manner in which neurotransmitter release may be regulated is and AC pathway [12, 13, 39] . In contrast, in the rabbit through modulation of PDE activity.
iris-ciliary body, the prejunctional a -adrenoceptors do 2
The principal intracellular target for cAMP in mamappear to be negatively coupled to adenylyl cyclase, which malian cells is the PKA [35] although some effects of this contributes to autofeedback regulation of NA release [11] . cyclic nucleotide might also be mediated by direct action These findings may help to explain the disparate nature of of cAMP on substrate molecules [36] . To provide direct the mechanisms underlying prejunctional receptor-medievidence for the involvement of this kinase in facilitating ated neuromodulation. the EFS-evoked neurotransmitter release, we applied three Another interesting feature of the present study is that different site-selective activators of PKA (i.e. 6-Phealthough AC-cAMP pathway appears to be involved in the cAMP, 8-AHA-cAMP, Sp-5, 6-DCl-cBIMPS). This combineurotransmitter release at high frequency of stimulation nation of drugs together activate both the A-and B-sites of both in artery and vein, this pathway seems to play a both type I and type II PKA [37, 38] . This combination of greater role in the vein. Intense activation of sympathetic drugs led to an increase of the EFS-evoked overflow of nervous system as initiated by hemorrhage, intense exer-NA at 16 Hz but not at 4 Hz, providing further evidence cise or stress results in marked constriction primarily of that facilitation of neurotransmitter release at higher freveins [40] , which results in increases in venous return and quency of stimulation is mediated by PKA. Therefore, central venous pressure, factors important in increasing direct activation of endogenous PKA enhances EFScardiac efficiency and output. Therefore, activation of evoked transmitter release at 16 Hz of stimulation. Inter-AC-cAMP-dependent pathway might participate in the estingly, direct PKA activation had more pronounced prolonged venoconstriction during sympathetic nervous effect in the artery than in vein, although AC-cAMP system hyperactivity. pathway seems to generally play a greater role in the vein.
In conclusion, activation of the AC-cAMP-PKA pathAlong these lines, it is particularly intriguing that the way does not play a significant role in modulating NA enhancing effect of ISO was abolished by the PKA release in canine mesenteric arteries and veins at low inhibitor PKI in the artery, whereas the ISO enhancstimulation frequencies. In contrast, AC-cAMP-PKA 14 -22 ing effect in the vein remained untouched. The latter pathway activation appears to be more important for finding suggests that in the artery a large portion of the neuromodulation at higher stimulation frequencies and ISO effect is mediated by PKA, whereas in the vein the hence during intense activation of the sympathetic nervous enhancing effect of ISO on NA release might be directly system. In addition, the AC-cAMP-mediated neuromodumediated by cAMP or be PKA-independent. lation seems to be more prominent in veins than in arteries Interestingly, while activation of AC-cAMP-PKA pathof the splanchnic circulation, whereas the contribution of way leads to enhancement of the EFS-evoked NA release PKA is more prominent in the arteries. at high frequency of stimulation, inhibitors of this pathway (i.e. SQ22,536, PKI and CMI) generally appear not to 14 -22 affect the EFS-evoked overflow of neurotransmitter neither A cknowledgements at high nor at low frequency of stimulation.
As discussed in the Introduction, one might anticipate This work was supported by US Public Health Service the AC-cAMP-PKA pathway-mediated neuromodulation Grant HL 60031 to V.M-Y. be more pronounced at lower frequency of stimulation if this pathway underlies the a -adrenoceptor-mediated 2 neuromodulation, since the autoregulation mediated by these receptors appear to be more prominent at low R eferences stimulation frequency. However, although all maneuvers for cAMP/AC / PKA pathway activation tend to influence neurotransmitter release at higher frequency of stimulation. ings agree with previous studies that report lack of a direct 
